PAREXEL Collaborates with Eli Lilly and Company to Develop China’s Clinical Research Workforce Read more
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets Read more
FDA grants priority review to Roche’s Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer Read more
Phase 3 Trial of Rova-T as Second-line Therapy for Advanced Small-Cell Lung Cancer (TAHOE Study) Halted Read more
Invitation from Ekkehard Leberer, Senior Director at Sanofi-Aventis Deutschland GmbH, Chair of next year’s RNA Therapeutics Conference in London Read more
Icagen enters into Collaboration to Develop and Commercialize Therapy for Neurological Diseases Read more
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA Read more
Novartis advances ligelizumab (QGE031) in urticaria to Phase III on basis of strong Phase II head-to-head data Read more